Pfizer Nears $9B Sale Of Baby Formula Unit To Nestle
Pfizer Inc. was reportedly on the verge Tuesday of selling its infant nutrition business to Swiss food giant Nestle SA in a deal worth $9 billion....To view the full article, register now.
Already a subscriber? Click here to view full article